Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue.
Prabhu L, Martin M, Chen L, Demir Ö, Jin J, Huang X, Motolani A, Sun M, Jiang G, Nakshatri H, Fishel ML, Sun S, Safa A, Amaro RE, Kelley MR, Liu Y, Zhang ZY, Lu T.
Prabhu L, et al. Among authors: fishel ml.
Genes Dis. 2022 Apr 13;10(1):267-283. doi: 10.1016/j.gendis.2022.04.001. eCollection 2023 Jan.
Genes Dis. 2022.
PMID: 37013054
Free PMC article.